NSC |
Compound |
Enrichment |
Correlation |
NSC 752892 |
N-[4-(4-Benzoylamino-pyrrolo[3,2-c]pyridin-1-yl)-phenyl]-4-(4-morpholin-4-yl)-3-trifluoromethylbenzamide |
0.0284045326811618 |
0.1816189 |
NSC 75520 |
Thymidine, .alpha.,.alpha.,.alpha.-trifluoro- (8CI 9CI) |
0.0284045326811618 |
0.13558316 |
NSC 758845 |
Null |
0.0284045326811618 |
0.013281038 |
NSC 87500 |
Solacongestidine |
0.0284045326811618 |
0.043002669 |
NSC 132791 |
Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo |
0.0286383688883668 |
0.078270366 |
NSC 149765 |
1,4-Pentanediamine, N4-(6-methoxy-8-quinolinyl)-, phosphate (1:2) (9CI) |
0.0286383688883668 |
0.091912588 |
NSC 175493 |
Iron, carbonyl(.eta.(5)-2,4-cyclopentadien-1-yl)(dimethylcarbamodithioato-S,S')- |
0.0286383688883668 |
0.25788541 |
NSC 176328 |
Ellipticine, 6-(3-aminopropyl)-, dihydrochloride |
0.0286383688883668 |
0.13856614 |
NSC 208885 |
Null |
0.0286383688883668 |
0.14883892 |
NSC 21683 |
Null |
0.0286383688883668 |
0.19451364 |